Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles

Innovent Acquires China Rights to Novel Immunoncology Candidate from Alector
Abbisko of Shanghai Raises $70 Million for Novel Oncology-Immunocology Candidates
Apexigen Adds $65 Million to C Round in Funding Led by China Investors
Mabpharm Out-Licenses US-EU Rights for COVID-19 Fusion Protein to Sorrento
Junshi Bio Teams Up with IMCAS to Develop Neutralizing Antibodies for COVID-19
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China